Research and Development

In 2017 Donald Trump signed the Tax Cuts and Jobs Act (TCJA), creating billions of dollars in tax rate cuts …

Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …

Doctors have been urged to be vigilant for signs of stroke after three rare instances have occurred in Oxford-AstraZeneca patients. …

The past week has seen lots of positive COVID-19 news; a French study has found that dogs can detect COVID-19 …

A school-based human papillomavirus (HPV) vaccination study programme, led by Monash University and Alfred Health, found a 70% reduction in …

Moderna’s TeenCOVE study, involving 3,700 adolescents aged 12 to less than 18 years old, observed no cases of COVID-19 after …

Ori Biotech and Vineti have announced a strategic partnership to produce pre-integrated solutions to fast-track and streamline the manufacture and …

The past week has seen lots of positive COVID-19 vaccine news; the Pfizer-BioNTech vaccine can be refrigerated much longer than …

Amphotericin B, an anti-fungal drug used to treat the rare infection mucormycosis, or ‘black fungus’, is in short supply across …

The first ever UK medical cannabis study has found significant improvements in anxiety, pain, and sleep in patients following treatment …

Artificial intelligence (AI) pharmatech company, Exscientia, has announced a collaboration with Bristol Myers Squibb to accelerate the discovery of small …

BD has announced plans to build a new €160 million manufacturing plant in Zaragoza, located in the Aragon region of …

The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.

The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …